Financhill
Back

ITeos Therapeutics Quote, Financials, Valuation and Earnings

ITeos Therapeutics Price Quote

$7.69
+0.01 (+-3.21%)
(Updated: December 14, 2024 at 5:38 AM ET)

ITeos Therapeutics Key Stats

Sell
36
ITeos Therapeutics (ITOS) is a Sell

Day range:
$7.44 - $7.89
52-week range:
$7.54 - $18.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.46%

Volume:
658K
Avg. volume:
506.8K
1-year change:
-30.05%
Market cap:
$290.3M
Revenue:
$12.6M
EPS:
$-3.15

How Much Does ITeos Therapeutics Make?

Data Unavailable

Is ITeos Therapeutics Growing As A Company?

Data Unavailable

ITeos Therapeutics Stock Price Performance

What Is ITeos Therapeutics 52-Week High & Low?

ITeos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ITeos Therapeutics?

Is ITeos Therapeutics Cash Flow Positive?

  • What Is ITOS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$117.4M
  • What Is ITeos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $122.3M
  • What Is ITeos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$83.2M

ITeos Therapeutics Return On Invested Capital

Data Unavailable

ITeos Therapeutics Earnings Date & Stock Price

ITeos Therapeutics Competitors

ITeos Therapeutics Dividend Yield

ITeos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 9.87%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 34.50
Upside from Last Price: 349.22%

Major Shareholders

  • How many ITOS shares are owned by institutional investors?
    55.6M ITOS shares are owned by institutional investors
  • How many ITOS shares are owned by insiders?
    293.2K ITOS shares are owned by insiders